T

his hasn’t been a great year for companies promising to revolutionize blood draws. But startup Velano Vascular is no Theranos. The company, based in San Francisco, has received positive notice for its FDA-approved device, dubbed PIVO, which lets hospital clinicians draw blood through an existing IV line. We chatted with CEO Eric Stone.

How does your technology work?

Inpatient blood draws are critical medical procedures, but they’re performed so frequently that they turn patients into pincushions.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy